Gene: SCRN2
Official Full Name: secernin 2provided by HGNC
Gene Summary: Predicted to enable cysteine-type exopeptidase activity and dipeptidase activity. Predicted to be involved in proteolysis. Located in extracellular exosome. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO23728 | SCRN2 Knockout cell line (HeLa) | Human | SCRN2 | 1:3~1:6 | Negative | Online Inquiry |
KO23729 | SCRN2 Knockout cell line (HCT 116) | Human | SCRN2 | 1:2~1:4 | Negative | Online Inquiry |
KO23730 | SCRN2 Knockout cell line (HEK293) | Human | SCRN2 | 1:3~1:6 | Negative | Online Inquiry |
KO23731 | SCRN2 Knockout cell line (A549) | Human | SCRN2 | 1:3~1:4 | Negative | Online Inquiry |
SCRN2 Gene Knockout Cell Lines are genetically engineered cellular models that have been specifically designed to investigate the biological functions and implications of the SCRN2 gene. This product is vital for researchers focusing on genetic regulation, cell signaling mechanisms, and the role of SCRN2 in various diseases, particularly in neurodevelopmental and psychiatric disorders.
The SCRN2 knockout cell lines facilitate a deep exploration of gene function by completely eliminating the SCRN2 expression, thereby allowing researchers to observe any subsequent phenotypic changes and molecular interactions. The mechanisms by which these cell lines operate rest on CRISPR-Cas9 technology, which enables precise gene editing and ensures that the genetic alterations are stable and heritable throughout cellular passages. This tool accelerates the study of gene function and interaction pathways, providing insights that are crucial for comprehending complex biological systems and disease mechanisms.
The scientific importance of SCRN2 Gene Knockout Cell Lines is underscored by their applications in both academic and clinical research settings. They serve as essential tools for elucidating the role of SCRN2 in neurodevelopment and its implications in conditions such as schizophrenia, autism spectrum disorders, and other related pathologies. By promoting a better understanding of these diseases at the molecular level, these cell lines can lead to innovative therapeutic strategies and intervention approaches.
One of the primary advantages of the SCRN2 Gene Knockout Cell Lines is their specificity and reproducibility compared to traditional silencing methods, such as RNA interference or dominant-negative constructs. These cell lines provide more consistent results due to the complete gene knockout, reducing variables that could arise from partial gene silencing. Researchers will find that these cell lines streamline experimental designs, enhance data reliability, and expedite the pace of research.
The value of SCRN2 Gene Knockout Cell Lines lies in their capacity to enhance scientific discovery and clinical relevance, making them indispensable tools for researchers and healthcare professionals dedicated to understanding and mitigating the effects of genetic components in disease. Our company is committed to providing high-quality biological products and innovative genetic tools that empower researchers to advance their studies and ultimately improve human health outcomes.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.